Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials.

A Vallano; V Fernandez-Duenas; G Garcia-Negredo; MA Quijada; CP Simon; ML Cuffí; L Carbonell; S Sanchez; JM Arnau; F Ciruela

Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials.

A Vallano, V Fernandez-Duenas, G Garcia-Negredo, MA Quijada, CP Simon, ML Cuffí, L Carbonell, S Sanchez, JM Arnau, F Ciruela

Departament de Farmacologia, de Terapèutica i de Toxicologia

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

13 Cites (Scopus)

Idioma original	Anglès
Pàgines (de-a)	1128-1142
Nombre de pàgines	14
Revista	CNS and Neurological Disorders - Drug Targets
Estat de la publicació	Publicada - de des. 2013

Altres arxius i enllaços

Com citar-ho

@article{a9a801bc9e2f44d68048ecf880f65039,

title = "Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials.",

author = "A Vallano and V Fernandez-Duenas and G Garcia-Negredo and MA Quijada and CP Simon and ML Cuff{\'i} and L Carbonell and S Sanchez and JM Arnau and F Ciruela",

year = "2013",

month = dec,

language = "English",

pages = "1128--1142",

journal = "CNS and Neurological Disorders - Drug Targets",

issn = "1871-5273",

publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials.

AU - Vallano, A

AU - Fernandez-Duenas, V

AU - Garcia-Negredo, G

AU - Quijada, MA

AU - Simon, CP

AU - Cuffí, ML

AU - Carbonell, L

AU - Sanchez, S

AU - Arnau, JM

AU - Ciruela, F

PY - 2013/12

Y1 - 2013/12

UR - http://europepmc.org/abstract/med/24040811

UR - https://www.scopus.com/pages/publications/84891706526

M3 - Article

C2 - 24040811

SN - 1871-5273

SP - 1128

EP - 1142

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

ER -